Here are five takeaways:
1. From 2016 to 2020, the market is expected to increase at a compound annual growth rate of 4.84 percent.
2. Surgeons’ preference for minimally invasive spinal cord stimulation devices has spurred market growth.
3. Advances in high-frequency technologies leading to more implant procedures are also driving market growth.
4. In addition to Medtronic, the vendors leading the market include Boston Scientific, Nevro and St. Jude Medical.
5. Other vendors include Greatbatch and Stimwave.
More articles on devices:
Amedica’s Q2 revenue drops 16%, adds OEM partner: 8 things to know
JRI Orthopaedics completes Sheffield Medical acquisition: 4 takeaways
Misonix supports Texas Back Institute’s surgeon’s Uganda Spine Surgery Mission: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
